Comment on AstraZeneca cancer drug, companion test approved

AstraZeneca cancer drug, companion test approved

TRENTON, N.J. (AP) — U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC. The drug is for women whose ovarian cancer is associated with certain defective genes and whose cancer persists after multiple treatments. Women with mutated BRCA genes have a higher risk of getting ovarian cancer.Read more on NewsOK.com

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News